A human tissue welding technique was successfully implemented in breakthrough laryngectomy and chondrectomy procedures at the Kiev Regional Clinical Hospital between May and November of this year. Dr. Rustem A. Abizov, Otorinolaryngology chair at the Kiev Medical Academy for Postgraduate Studies, used the live biological tissue welding/bonding technology developed by a subsidiary of CSMG Technologies Inc.

The electro welding/bonding technology devices from Live Tissue Connect were used to surgically treat patients suffering from larynx cancer.

CryoLife Inc. has received CE Mark and Health Canada approval for a new rigid applicator tip for its BioGlue Surgical Adhesive. The BioGlue Rigid Applicator Tip is 34 cm in length, enabling accurate delivery of BioGlue beyond the previous 27 cm.

BioGlue was first introduced to the European market in 1998 and is accepted and used by surgeons worldwide. Clinically proven to provide immediate hemostasis, BioGlue is effective in bonding, sealing and reinforcing soft tissue in a broad range of indications.

Exelixis Inc. and Bristol-Myers Squibb Co. have announced a collaborative agreement to develop and commercialize novel targeted therapies for the treatment of cancer.

Eastman Kodak Co.’s health group announced immediate price increases worldwide on all its medical imaging films and related supplies — the second such action Kodak has taken in 2006.

Kodak cited continued high costs of raw materials, especially silver, as the primary reason for the price hikes. The increases range from 8 to 12 percent, depending on products and markets around the world.

A diagnostic device that resembles a mammography unit can detect breast tumors as tiny as one-fifth of an inch in diameter, according to researchers at Mayo Clinic, who helped develop the technology along with industry collaborators Gamma Medica Inc. and GE Healthcare.

A prospective clinical study shows that the GeneSearch Breast Lymph Node Assay, a gene-based diagnostic test, has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study, sponsored by Veridex LLC, the GeneSearch demonstrated overall sensitivity at least 10 percentage points higher than intra-operative tests.

IMCO-STAT, wireless communications technology software developed by IMCO Technologies, announced today that it has received FDA 510(k) clearance to sell to the healthcare industry, extending its presence in hospitals, imaging centers, medical clinics and orthopaedic practices.

The long-time dream of a vaccine to prevent breast cancer may be a step closer to reality, according to new research presented this week at the 29th Annual San Antonio Breast Cancer Symposium. Researchers presented the results of a vaccine
trial targeting HER2, a protein that is related to cell growth and is commonly overexpressed in breast cancer cells.

A Navy plan to test a blood substitute on civilian trauma victims should remain on hold, federal health advisers recommended Thursday, saying the experiment's risks outweigh its benefits.

The nonbinding vote appears to be the latest blow to the Navy, which has repeatedly sought FDA approval to test the product, derived from cow blood, on roughly 1,100 trauma victims in emergency situations. It proposes doing so without obtaining the customary informed consent of patients.

During last year's influenza season, the number of infants and toddlers in the U.S. who were vaccinated against the flu varied by tenfold between different locations, according to a new report.

Kathy Fredrickson, at the Arizona Department of Health Services, and associates tallied levels of vaccination among children 6 to 23 months old during the 2005-2006 flu season at sentinel sites in Arizona, Michigan, Minnesota, Montana, Oregon and the District of Columbia.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now